Posted by Michael Wonder on 27 Nov 2022
Cheaper medicines for high cholesterol and chronic heart failure
28 November 2022 - From 1 December 2022, Australians with high cholesterol, chronic heart failure, and a potentially life-threatening blood cell condition will have access to new and updated medicines under the PBS.
Repatha (evolocumab) will be extended on the PBS to include more people who have hypercholesterolaemia.
